News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Daily News FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One L.A. McKeown June 19, 2019
News Daily News No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds L.A. McKeown March 01, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents Shelley Wood September 22, 2018
News Daily News ‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients Michael O'Riordan August 23, 2018
News Daily News REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months L.A. McKeown February 11, 2018
News Daily News Vascular Solutions Retira los Catéteres Gemelos de Doble Vía Michael O'Riordan October 06, 2016
News Daily News Vascular Solutions Recalls Twin-Pass Dual-Access Catheters Michael O'Riordan October 06, 2016
News Industry News Zilver® PTX® with Thumbwheel Delivery System Launched in France September 23, 2016
News Conference News VIVA 2016 Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent L.A. McKeown September 20, 2016
News Industry News Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial February 21, 2016
News Daily News Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year L.A. McKeown August 10, 2015
News Daily News El Injerto de Perfil Más bajo para TEVAR Confirma la Seguridad y Éxito del Dispositivo a 1 Año L.A. McKeown August 10, 2015
News Daily News EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes L.A. McKeown February 26, 2015